Morphine Sulfate Injection Recalled for Lack of Sterility Assurance
Nephron Sterile Compounding Center is recalling Morphine Sulfate Injection syringes distributed nationwide due to lack of assurance of sterility. Approximately 43,385 syringes are affected.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This FDA Class II recall involves an injectable medication where sterility assurance is critical. Although sterility failures in injectables pose a serious potential health risk, no illnesses or adverse events have been reported, placing this in the risk-of-harm category without documented injury.
Plain-English summary
Nephron Sterile Compounding Center LLC is recalling Morphine Sulfate Injection, USP, 2 mg/2 mL (1 mg/mL) pre-filled syringes distributed nationwide in the United States. Approximately 43,385 syringes are affected by this recall.
The recall was initiated due to lack of assurance of sterility. The affected lot numbers and expiration dates are: MS2001A (Exp. 7/2/2022), MS2006A (Exp. 8/9/2022), MS2009A (Exp. 8/25/2022), MS2011A (Exp. 9/3/2022), and MS2017A (Exp. 10/2/2022). This is a prescription-only product from Nephron's 503B outsourcing facility.
No illnesses or adverse events have been reported in association with this recall. Healthcare providers and patients should contact their healthcare provider or pharmacist if they have questions about medication from the affected lots.
The recalled product
- Product
- Morphine Sulfate Injection, USP, 2 mg/2 mL (1 mg/mL) syringe, packaged in 5 x 2 mL Pre-Filled Syringes per carton, 6 x 5 Syringe Carton per case, Rx Only, Nephron 503B outsourcing facility, 4500 12th St. Extension, West Columbia, SC 29172, NDC: 69374-979-02
- Manufacturer
- Nephron Sterile Compounding Center LLC
- Category
- Drug — Pre-filled Syringe
- Hazard
- sterility-failure
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (10)
- Lots: MS2001A
- Exp. 7/2/2022
- MS2006A
- Exp. 8/9/2022
- MS2009A
- Exp. 8/25/2022
- MS2011A
- Exp. 9/3/2022
- MS2017A
- Exp. 10/2/2022
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27